Department of Obstetrics and Gynecology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.
Herbert Irving Comprehensive Cancer Center, New York, NY, USA.
J Matern Fetal Neonatal Med. 2021 Oct;34(20):3370-3376. doi: 10.1080/14767058.2019.1684471. Epub 2019 Nov 19.
Placenta accreta spectrum (PAS) is a spectrum of conditions in which the placenta is abnormally adherent and invades the uterine wall. This invasion can cause life-threatening hemorrhage and lead to significant adverse maternal outcomes. Numerous studies have shown an association between treatment of PAS at high volume, specialized centers and improved maternal outcomes; however, little is known about how these data have influenced practice.
The objective of the study was to examine the patterns of care for women with placenta accreta spectrum over time.
Data from New York Statewide Planning and Research Cooperative System (SPARCS) from 2000 to 2017 was used for this analysis. The study cohort comprised of women aged 15-54 years with PAS who underwent a hysterectomy during their delivery hospitalization. Study outcomes included severe maternal morbidity as defined by the Centers for Disease Control and Prevention, surgical complications, and transfusion. Hospitals were stratified into tertiles based on the volume of PAS hysterectomy cases. Patient demographic and clinical characteristics were compared across volume tertiles. Random intercept log-linear regression models with Poisson distributions and log link functions were fit to examine the association between hospital PAS volume and the outcomes of interest.
A total of 1958 women with PAS who underwent hysterectomy at 123 hospitals were identified. The number of hospitals providing care ranged from 46 centers in 2000 to 52 hospitals in 2016. The median hospital-level case volume of PAS was 1 (interquartile range [IQR], 1-2) in 2000 and rose slightly to 2 (IQR, 1-4) by 2016. The PAS volume cut-point for the top decile of hospitals was three cases in 2000 and increased to six cases in 2016. There was no significant change in the median travel distance for women with PAS over time. The rate of severe maternal morbidity increased significantly from 14.1% (95% CI: 7.8-24.0%) in 2000 to 19.0% (95% CI: 13.6-25.8%) in 2016. Transfusion occurred in 66.2% (95% CI: 54.6-76.1%) of cases in 2000 compared to 60.1% (95% CI: 52.3-67.4%) in 2016. Surgical complications occurred in 16.9% (95% CI: 9.9-27.3%) of cases in 2000 to 24.7% (95% CI: 18.6-32.0) in 2016. There was no difference in the adjusted rates of transfusion or surgical complications based on hospital volume. Compared to low-volume centers, the risk of severe maternal morbidity was reduced by 33% (aRR = 0.67; 95% CI: 0.50-0.90) at the intermediate volume centers.
There has been little change in the patterns of care for women with PAS in New York State. While the volume of patients with PAS has increased at the highest volume centers, a large number of relatively low-volume centers still provide care for a significant number of women with PAS.
胎盘植入谱系(PAS)是一种胎盘异常黏附并侵袭子宫壁的疾病谱。这种侵袭可能导致危及生命的出血,并导致严重的产妇不良结局。许多研究表明,在高容量、专业中心治疗 PAS 与改善产妇结局之间存在关联;然而,人们对这些数据如何影响实践知之甚少。
本研究旨在考察 PAS 患者的护理模式随时间的变化。
本分析使用了来自纽约州全州规划和研究合作系统(SPARCS)的数据,时间范围为 2000 年至 2017 年。研究队列包括在分娩住院期间接受子宫切除术的年龄在 15-54 岁之间的 PAS 患者。研究结局包括疾病预防控制中心定义的严重产妇发病率、手术并发症和输血。根据 PAS 子宫切除术病例数量将医院分层为三分位数。比较了不同体积三分位数之间的患者人口统计学和临床特征。使用泊松分布和对数链接函数的随机截距对数线性回归模型来检验医院 PAS 体积与感兴趣结局之间的关联。
共确定了 1958 名在 123 家医院接受 PAS 子宫切除术的患者。提供治疗的医院数量从 2000 年的 46 家中心到 2016 年的 52 家医院不等。PAS 的医院平均病例量中位数为 1(四分位距 [IQR],1-2)在 2000 年,到 2016 年略有上升至 2(IQR,1-4)。2000 年,前十分位数医院的 PAS 体积截点为 3 例,到 2016 年增加到 6 例。PAS 患者的平均旅行距离随时间没有明显变化。严重产妇发病率从 2000 年的 14.1%(95%CI:7.8-24.0%)显著上升至 2016 年的 19.0%(95%CI:13.6-25.8%)。2000 年有 66.2%(95%CI:54.6-76.1%)的病例需要输血,而 2016 年则为 60.1%(95%CI:52.3-67.4%)。2000 年有 16.9%(95%CI:9.9-27.3%)的病例发生手术并发症,而 2016 年则为 24.7%(95%CI:18.6-32.0)。根据医院容量,输血或手术并发症的调整率没有差异。与低容量中心相比,中容量中心严重产妇发病率的风险降低了 33%(ARR=0.67;95%CI:0.50-0.90)。
纽约州 PAS 患者的护理模式几乎没有变化。虽然 PAS 患者的数量在高容量中心有所增加,但仍有大量相对低容量的中心为大量 PAS 患者提供治疗。